Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Reversion of Ebolavirus Disease from a Single Intramuscular Injection of a pan-Ebolavirus Immunotherapeutic

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.06.475142Source: DataRank Database

Reversion of Ebolavirus Disease from a Single Intramuscular Injection of a pan-Ebolavirus Immunotherapeutic is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2022). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: greenTopics (18)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (17)

Robert W. Cross ORCID,Maria McCavitt-Malvido ORCID,Dafna M. Abelson ORCID,Viktoriya Borisevich,Krystle N. Agans ORCID

Live enrichment

PubMed:23304386 OpenAlex:https://openalex.org/W4205177085

National Institutes of Health

Grant: 5U19AI109711-04

Advancement of Treatments for Ebola and Marburg Virus Infections

National Institutes of Health

Grant: 5U19AI109762-04

Consortium for Immunotherapeutics Against Viral Hemorrhagic Fevers

National Institutes of Health

Grant: 5UC7AI094660-03

National Biocontainment Laboratories (NBLs) Operations Support

National Institutes of Health

Grant: 1U19AI142785-01

Advancement of Vaccines and Treatments for Ebola and Marburg Virus Infections

green

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2022/01/06/2022.01.06.475142.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2022.01.06.475142

repositoryhttps://doi.org/10.1101/2022.01.06.475142

Fields of Study

Viral Infections and Outbreaks ResearchSARS-CoV-2 and COVID-19 ResearchViral Infections and Vectors0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

EbolavirusVirologyMonoclonal antibodyMedicineOutbreakDiseaseEbola virusIntramuscular injectionAntibodyImmunologyBiologyInternal medicine

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being